Description
MECHLORETHAMINE TOPICAL GEL
First action · last action
2019-02-26 · 2019-02-26
Transactions
1
First transaction's obligation
$36,471
Base + all options value (sum of deltas)
$36,471
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70240
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-02-26+$36,471= $36,471
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-02-26 | +$36,471 | $36,471 | MECHLORETHAMINE TOPICAL GEL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI H7RDUVXHP8L3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24525N0877 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $14,560 | FY2025 |
| 36E79725A0008 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36F79725D0061 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79724A0004 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C24620F0088 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6850 · MISCELLANEOUS CHEMICAL SPECIALTIES | $36,471 | FY2020 |
| 36C24620N0274 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $36,471 | FY2020 |
Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626N1034 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,362 | FY2026 |
| 36C24626A0027 | PROGENICS PHARMACEUTICALS INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $0 | FY2026 |
| 36C24626N0890 | PROGENICS PHARMACEUTICALS INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $1,212,530 | FY2026 |
| 36C24626N0782 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $72,563 | FY2026 |
| 36C24626N0690 | PARTNER THERAPEUTICS, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $54,422 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24619N0678_3600_V797D70240_3600 · retrieved 2026-09-26.